Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q3 EPS of ($0.26), $0.01 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.